UCPA encourages men ages 55 to 69 to revisit their need for Prostate Cancer Screenings with their doctors.
The prostate gland normally tends to enlarge in the vast majority of males as they age. For many men, this growth can cause symptoms later in life.
Some researchers are concerned that prostate cancer can be so slow growing that the prescribed treatment and side effects are often worse than the potential consequences of inaction. However, without a PSA test, it would be impossible to know if an early stage cancer will be slow growing or if it is a more aggressive type that can quickly become fatal if left untreated.
As urology specialists with a long and successful track record of treating prostate cancer, our doctors firmly believe that PSA screenings remain essential to managing prostate health. Only when a “normal” baseline reading has been established (preferably by the age of 50) can your doctor watch for any dramatic jump in PSA readings which could indicate the need for urgent action. More
There are more than three million US cases of erectile dysfunction per year, making it a very common condition among men as they age. The symptoms can cause stress, relationship strain and low self-confidence. More
UCPA is proud to announce the opening of our new offices located at 815 Sir Thomas Court, in Harrisburg.
Pours for Prostates More
Friday, June 22, 2018
The Vineyard at Hershey
598 Schoolhouse Road, Middletown, PA
Men’s Prostate Health Seminar
Wednesday, April 25, 2018
5:30 p.m. Check-in, 6 p.m. Presentation
Colonial Golf and Tennis Club More
4901 Linglestown Road, Harrisburg
Prostate Cancer Support and Education Meeting More
“Getting Better with Age: You and Your Diet”
Thursday, April 19, 2018
6 – 8 p.m.
Urology of Central PA, 100 Corporate Center Dr., Ste. 100, Camp Hill
Save the date for the 2018 Pennsylvania Prostate Cancer Conference! Our annual conference will be held on Saturday, September 22, 2018, from 8 a.m. to 1 p.m. at The Hotel Hershey. The conference will feature educational presentations by physicians for clinical staff and patients.
Sponsorship and Exhibitor opportunities are available by contacting Kristine Warner at firstname.lastname@example.org. More
There is encouraging news for those coping with the challenges of an enlarged prostate or benign prostatic hyperplasia (BPH). Recently, the U.S. Food and Drug Administration (FDA) has cleared new indications for the UroLift® System, a minimally invasive procedure that inserts permanent implants in the urethra, relieving prostate obstructions. More
For those done having children, a vasectomy may seem like a good solution for permanent birth control, and urologic practices have figured a way to motivate interested men to schedule the procedure: the promise of recuperating while watching a few days of NCAA March Madness. More
Since the release of the 2012 screening recommendations for prostate cancer, the controversy surrounding PSA testing and prostate cancer treatment has erupted and has lacked a clear direction and concise strategy.